{"disease":{"id":"congenital-blindness","name":"congenital blindness"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03968991","title":"VISIODOL: Validation of the VISIODOL® Scale","phase":"NA","overall_status":"TERMINATED","enrollment_count":37,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03913130","title":"Extension Study to Study PQ-110-001 (NCT03140969)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Laboratoires Thea","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}